Vitality Watch

Dossier rss preclinical 06-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Growth Hormone Receptor Antagonism Extends Lifespan

Key claim: Growth hormone receptor antagonism extends lifespan.

Abstract

Aging Cell, Volume 25, Issue 9, September 2026.

Why this matters

The GH/IGF-1 axis is one of the most reproducible longevity levers in mammals, but until now the lifespan evidence came almost entirely from genetic dwarf and GHRKO mouse models. A pharmacological GHR antagonist reproducing that phenotype moves the axis one step closer to a druggable geroprotector class, though the evidence remains preclinical and sits alongside — not above — the existing rapamycin/mTOR and metformin animal data.

Source

Link

Briefing card

Growth Hormone Receptor Antagonism Extends Lifespan
Stage: preclinical · rss · 06-sep-2026

Growth hormone receptor antagonism extends lifespan.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://onlinelibrary.wiley.com/doi/10.1111/acel.70697?af=R

build build 880 · 2bcef25 · 2026-11-18